Banik SS - Search Results

1

N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo.

Armbruster BN, Banik SS, Guo C, Smith AC, Counter CM. Armbruster BN, et al. Among authors: banik ss. Mol Cell Biol. 2001 Nov;21(22):7775-86. doi: 10.1128/MCB.21.22.7775-7786.2001. Mol Cell Biol. 2001. PMID: 11604512 Free PMC article.

2

The nucleolar localization domain of the catalytic subunit of human telomerase.

Etheridge KT, Banik SS, Armbruster BN, Zhu Y, Terns RM, Terns MP, Counter CM. Etheridge KT, et al. Among authors: banik ss. J Biol Chem. 2002 Jul 5;277(27):24764-70. doi: 10.1074/jbc.M201227200. Epub 2002 Apr 15. J Biol Chem. 2002. PMID: 11956201 Free article.

3

C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity.

Banik SS, Guo C, Smith AC, Margolis SS, Richardson DA, Tirado CA, Counter CM. Banik SS, et al. Mol Cell Biol. 2002 Sep;22(17):6234-46. doi: 10.1128/MCB.22.17.6234-6246.2002. Mol Cell Biol. 2002. PMID: 12167716 Free PMC article.

4

Mutational analysis defines a minimum level of telomerase activity required for tumourigenic growth of human cells.

Hamad NM, Banik SS, Counter CM. Hamad NM, et al. Among authors: banik ss. Oncogene. 2002 Oct 10;21(46):7121-5. doi: 10.1038/sj.onc.1205860. Oncogene. 2002. PMID: 12370834

5

Characterization of interactions between PinX1 and human telomerase subunits hTERT and hTR.

Banik SS, Counter CM. Banik SS, et al. J Biol Chem. 2004 Dec 10;279(50):51745-8. doi: 10.1074/jbc.M408131200. Epub 2004 Sep 20. J Biol Chem. 2004. PMID: 15381700 Free article.

6

Human arteries engineered in vitro.

McKee JA, Banik SS, Boyer MJ, Hamad NM, Lawson JH, Niklason LE, Counter CM. McKee JA, et al. Among authors: banik ss. EMBO Rep. 2003 Jun;4(6):633-8. doi: 10.1038/sj.embor.embor847. EMBO Rep. 2003. PMID: 12776184 Free PMC article.

7

Blood vessels engineered from human cells.

Poh M, Boyer M, Solan A, Dahl SL, Pedrotty D, Banik SS, McKee JA, Klinger RY, Counter CM, Niklason LE. Poh M, et al. Among authors: banik ss. Lancet. 2005 Jun 18-24;365(9477):2122-4. doi: 10.1016/S0140-6736(05)66735-9. Lancet. 2005. PMID: 15964449

8

Recurrent branch retinal vein occlusion with factor V leiden mutation.

Banik S, Bhutto HU, Bagga P. Banik S, et al. Eye (Lond). 2006 Aug;20(8):948-9. doi: 10.1038/sj.eye.6702060. Epub 2005 Aug 19. Eye (Lond). 2006. PMID: 16113634 No abstract available.

9

Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets.

Banik SSR, Kushnir N, Doranz BJ, Chambers R. Banik SSR, et al. MAbs. 2023 Jan-Dec;15(1):2273018. doi: 10.1080/19420862.2023.2273018. Epub 2023 Dec 5. MAbs. 2023. PMID: 38050985 Free PMC article. Review.

10

Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.

Fong RH, Banik SS, Mattia K, Barnes T, Tucker D, Liss N, Lu K, Selvarajah S, Srinivasan S, Mabila M, Miller A, Muench MO, Michault A, Rucker JB, Paes C, Simmons G, Kahle KM, Doranz BJ. Fong RH, et al. Among authors: banik ss. J Virol. 2014 Dec;88(24):14364-79. doi: 10.1128/JVI.01943-14. Epub 2014 Oct 1. J Virol. 2014. PMID: 25275138 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page